Stock listing
Generate Biomedicines, Inc.
Selected listing: GENB · BX · CHF · CH
Generate Biomedicines, Inc. (BX Swiss: GENB), Health Technology. Latest release Oct 1, 2026: Roswell Park, Generate Biomedicines Launch Exclusive Clinical…
- Ticker
- BX Swiss: GENB
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BX Swiss
- Currency
- CHF
About Generate Biomedicines, Inc.
Generate Biomedicines, Inc. is a public company listed under the ticker GENB, operating in the American market. Generate Biomedicines focuses on developing innovative biomedicine solutions.
Latest news from Generate Biomedicines, Inc.
Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of ‘Armored’ CAR T Therapy for Ovarian Cancer
September 30, 2026
Generate Biomedicines Inc. to Participate in September Investor Conferences
September 8, 2026
Generate Biomedicines Inc. Reports Second Quarter 2026 Financial Results and Provides Business Update
August 6, 2026
Generate Biomedicines Inc. to Participate in Goldman Sachs 47th Annual Global Healthcare Conference
May 28, 2026
Generate Biomedicines, Inc. Reports First Quarter 2026 Financial Results and Provides Business Update
May 7, 2026
Research Generate Biomedicines, Inc.
Generate Biomedicines, Inc. company profile
View the public company page for Generate Biomedicines, Inc. on 6ix.
Generate Biomedicines, Inc. news
Read company news and market updates connected to Generate Biomedicines, Inc..
Generate Biomedicines, Inc. investor events
Find investor webinars, events, and replay context for Generate Biomedicines, Inc..